MozecTM NC Rx PTCA Balloon Dilatation Catheter MNC45013Recalls & reported problems
Meril Life Sciences Private Limited · MozecTM NC Rx PTCA Balloon Dilatation Catheter, 4.50 mm x 13 mm, Rapid Exchange · Class 2
All models of MozecTM NC Rx PTCA Balloon Dilatation Catheter (15)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 1
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 18906029359527), received between Oct 21, 2023 and Oct 21, 2023 — classified as 1 malfunction.
The most frequently reported specific device problem is “Deflation Problem” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Deflation Problem1
Patient problems
- No Clinical Signs, Symptoms or Conditions1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
MalfunctionOct 21, 2023Deflation Problem; Deflation Problem
AS REPORTED, 4.50X13 MM MOZEC¿ NC RX PTCA BALLOON DILATATION CATHETER WAS USED FOR THE PROCEDURE. THE TARGET LESION WAS MID RCA WITH SEVERE TORTUOSITY, 80% CALCIFICATION AND 80% STENOSIS. THE BALLOON WAS PLACED MID TO PROXIMAL IN THE RCA. THE BALLOON DID NOT DEFLATE DURING THE PROCEDURE. (THE BALLON TOOK 1.5 - 2 MINUTES TO DEFLATE). THE DEVICE WAS USED IN 62 YEARS OLD MALE PATIENT. THE TARGET LESION WAS MID RCA WITH SEVERE TORTUOSITY, 80% CALCIFICATION AND 80% STENOSIS. THE DEVICE WAS STORED AND HANDLED PER THE IFU. THERE WERE NO ANOMALIES NOTED TO THE DEVICE WHEN IT WAS TAKEN OUT OF THE PACKAGING. THERE WAS NO DIFFICULTY IN REMOVING THE PRODUCT FROM THE HOOP. THERE WAS NO DIFFICULTY IN REMOVING THE STYLET. THE DEVICE WAS PREPPED PER THE IFU. THE DEVICE WAS PREPPED NORMALLY. THERE WAS NO ANOMALY NOTED DURING OR AFTER THE DEVICE WAS PREPPED. THE PRODUCT WAS INSPECTED PRIOR TO USE AND APPEARED TO BE NORMAL. THERE WAS NO UNUSUAL FORCE USED DURING THE LOADING ON GUIDEWIRE. THERE WAS NO RESISTANCE/FRICTION EXPERIENCED WHILE INSERTING THE DEVICE THROUGH THE ROTATING HEMOSTATIC VALVE. THERE WAS NO RESISTANCE/FRICTION EXPERIENCED WHILE INSERTING THE DEVICE THROUGH THE GUIDE CATHETER. THERE
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 17981741 ↗
Other Catheters, Transluminal Coronary Angioplasty, Percutaneous devices
- MINI TREK™ 1012270-15Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous223 reports
- Maverick²™ H7493892815200Boston Scientific Corporation · Catheters, transluminal coronary angioplasty, percutaneous1 death203 reports
- MINI TREK™ 1012270-12Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous162 reports
- Maverick²™ H7493892820200Boston Scientific Corporation · Catheters, transluminal coronary angioplasty, percutaneous161 reports
- NC TREK 1012454-08Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous2 recalls59 reports
- TREK™ 1012272-15Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous2 deaths158 reports
- NC TREK 1012453-12Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous1 recall84 reports
- NC TREK 1012453-15Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous1 recall1 death83 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page